TruBridge Amends Limited Duration Stockholder Rights Plan, Increasing Threshold To 15%
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (the “Company”), a healthcare solutions company, announced today that its Board of Directors (the...
Year: 2024
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first...
Revelyst Announces Chief Supply Chain Officer
Revelyst is thrilled to appoint longtime supply chain and business operations leader Joe Beck to the position of Chief Supply...
Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs
Toronto, Ontario--(Newsfile Corp. - April 23, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Berenson Acquisition Corp. I Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
Reaffirms commitment to regaining compliance with the NYSE American continued listing standardsNew York, New York--(Newsfile Corp. - April 23, 2024)...
Lash ME NYC Promotes New Exhaustive Range of Lash Extensions, From Subtle to Dramatic
Whether the preference is for understated lashes or a high-glam look, Lash Me NYC's customized luxurious lash solutions make sure...
Nature’s Answer Introduces Maca Root Extract to Its Range of Bio-Chelated Extracts
Maca Root Extract; A true 1:1 fluid extract containing 1,000 mg per serving that is natural, Non-GMO Project Verified with...
SpendMend Achieves HITRUST Implemented, 1-Year (I1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats
HITRUST certification validates SpendMend is operating leading security practices to protect sensitive information.GRAND RAPIDS, MI / ACCESSWIRE / April 23,...
CNS Pharmaceuticals to Present at the LSX World Congress 2024
Presentation on Monday, April 29th at 4:15 PM (GMT+1)HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc....
Nava Health Expands Columbia Location to Meet Growing Demand for Integrative and Functional Medicine
Nava Health in Columbia Increases Space as Local Demand Shows No Signs of Slowing COLUMBIA, MD / ACCESSWIRE / April...
New Resources Explain How Court Ruling Improves Insured Consumer Access to Medications
English and Spanish materials include information on a 2023 court decision that requires health plans to count copay assistance towards...
ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network’s Handheld Ultrasound Devices
LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud...
Tribun Health, Winner of the I-Nov Competition of Bpifrance, Obtains Funding of Over €600,000 for Its Pathomix Project
PARIS, FRANCE / ACCESSWIRE / April 23, 2024 / Tribun Health, a major player in software solutions for digital pathology,...
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
ORLANDO, FL / ACCESSWIRE / April 23, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that following its engagement by Fit...
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture...
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious ConditionsSOLANA BEACH,...
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in...
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading...